Photo, Mark Mandel

Mark Mandel

Partner
Baker & McKenzie LLP

Biography

Mark Mandel is Chair of the North America Capital Markets Practice Group, member of the Global Capital Markets Steering Committee and Co-Chair of the Transactional Practice Group in New York and Miami. Mr. Mandel has been named by Legal 500 as one of the leading lawyers in the US for mergers and acquisitions and recognized by IFLR 1000 for mergers and acquisitions and capital markets. Mark has also been designated a "stand-out lawyer" by Acritas Stars. Mark was named in Attorney Intel’s Top 25 M&A Attorneys of 2024.

Practice Focus

Mark advises public and private companies and financial sponsors in connection with investments, mergers, acquisitions, divestitures, unsolicited and friendly tender offers, proxy contests, complex joint ventures, public offerings and private placements of securities and restructurings. He regularly represents clients in competitive auctions, both as bidders and sellers. He also regularly advises boards of directors and special committees on corporate governance and fiduciary duties.

Representative Legal Matters

Mark has provided counsel to the following:

  • Olink Holding AB (publ) in its USD 3.1 billion sale to Thermo Fisher Scientific.
  • Numab Therapuetics in its USD 1.25 billion sale to Johnson & Johnson of its subsidiary, Yellow Jersey Therapeutics, which holds its phase 2-ready atopic dermatitis bispecific antibody NM26.
  • Cummins Inc. in the global carve-out and IPO split-off of its filtration business, Atmus Filtration Technologies Inc., with Goldman Sachs and JP Morgan Securities.
  • Apollo Global Management affiliated funds in their EUR 500 million investment in European gambling and lottery company SAZKA Group.
  • Brookfield Infrastructure in the sale of its 99.2% interest in Empresa de Energía de Boyacá (EBSA) to Northland Power Inc. for COP 2.665 trillion.
  • Hudbay Minerals in its USD 402 million registered offering of common shares with RBC and BMO.
  • Aurora Acquisition Corp. in its USD 6.9 billion de-SPAC transaction with Better HoldCo, Inc. and its PIPE financing with SoftBank and Novator Capital.
  • Hudbay Minerals Inc. in its USD 439 million acquisition of Copper Mountain Mining Corporation.
  • Teranga Gold in its CDN 2.6 billion business combination with Endeavour Mining.
  • Pointsbet Holdings Ltd. in its USD 393.6 million media partnership with NBC Sports and its sale of a 4.9% equity interest to NBCUniversal.
  • Grupo SBF S.A. in its unsolicited offer for all of the outstanding shares of Netshoes.
  • PJT Partners LP, financial advisor to the Special Committee of Credible Labs Inc., in connection with the USD 265 million acquisition by Fox Corporation.
  • Grupo SBF in its USD 180 million offering of shares in a Rule 144A / Regulation S transaction.
  • Spectral Medical in its offering of units consisting of one common share and one-half of one common share purchase warrant with Paradigm Capital.
  • KKR and York Capital in the acquisition of 23 chemical tankers and 4 LPG carriers from Berlian Laju Tanker.
  • Arcaptia in the USD 639.3 million sale of Fountains Senior Living Holdings’ 15 continuing care retirement communities to NorthStar Healthcare Income.
  • Sahara India Pariwar in its USD 575 million acquisition of an interest in the hotel, retail and condominium hotel units of The Plaza Hotel from El Ad US Holding; and its joint venture with Kingdom Holding.
  • Palladian Capital in the sale of National Truck Protection to Kinderhook Industries.
  • Votorantim Cimentos SA in the exchange of cement plants in Brazil for Lafarge SA’s 17.28% interest in Cimentos de Portugal SGPS SA (CIMPOR).
  • Linn Energy creditors in the USD 7.7 billion restructuring and the USD 530 million rights offering backstopped by certain Linn noteholders.
  • ITR Concession Company (Indiana Toll Road) creditors in the USD 5.7 billion reorganization and sale to IFM Investors.
  • AMR Corporation creditors in connection with the USD 11 billion merger with US Airways Group, giving the creditors control of the combined airline.
  • TORM creditors in the USD 1.4 billion restructuring, including the acquisition of vessels owned by affiliates of Oaktree Capital Management.
  • Teranga Gold in its unsolicited takeover bid for Oromin Exploration.
  • Hudbay Minerals in its USD 555 million unsolicited takeover bid for Augusta Resource.
  • Visa Inc. in its USD 19.65 billion initial public offering with JP Morgan Chase and Goldman Sachs as well as the Visa enterprise in its global reorganization to create Visa Inc.
  • Tahoe Resources in the secondary offering of CAD 1 billion of Tahoe common shares held by Goldcorp.
  • Primero Mining in the secondary offering of CAD 224 million of Primero common shares held by Goldcorp.
  • Campbell Soup Company's designated underwriters counsel.
  • Magna Entertainment Inc.'s Special Committee of the Board of Directors in connection with various transactions.

Professional Associations and Memberships

Mark has served on the following boards and committees:

  • Mount Sinai Hospital, Department of Medicine - Advisory Board
  • AJC Westchester / Fairfield - Board
  • Ontario Securities Commission - Securities Advisory Committee
  • Canadian Society of New York - Board
  • Canadian Association of New York - Board

Admissions

  • New York~United States
  • Ontario~Canada (practice outside Ontario)
  • U.S. Supreme Court~United States

Education

  • University of Chicago (LL.M.)
  • University of Toronto (LL.B.)
  • University of Toronto (B.A.)

Languages

  • English
  • Mark has been a guest lecturer at the University of Pennsylvania Carey Law School for the course Structuring Private Equity and Venture Capital Transactions.
  • Co-author, "Guide to IPO" Harvard Law School Forum on Corporate Governance, August 10, 2023
  • Speaker "The State of the M&A Market: Where are Successful Dealmakers Finding Opportunities?" The Deal Economy 2023: Predictions and Perspectives Conference June 2023
  • Mark is a co-author of The IPO and Public Company Primer: A Practical Guide to Going Public, Raising Capital and Life as a Public Company (RR Donnelley).
  • Co-author, "United States: SEC proposes rules for further disclosure and enhanced investor protections regarding SPACs" Baker McKenzie Client Alert, April 5, 2022

Other publications authored include:

  • When Should a Board Form a Special Committee to Run the Sale of a Controlled Public Company? – published in Boardroom Briefing: Mergers & Acquisitions.
  • Sellers Avoid a Tax Bite with Sponsored Spinoffs – published in Mergers & Acquisitions.
  • Wielding a Club "Proliferating Club Deals Pose Special Challenges to Counsel" – published in the New York Law Journal.